Unique ID issued by UMIN | UMIN000013714 |
---|---|
Receipt number | R000016012 |
Scientific Title | Safety test of inserting small gold fiducials for prostate cancer |
Date of disclosure of the study information | 2014/04/15 |
Last modified on | 2020/04/23 21:41:35 |
Safety test of inserting small gold fiducials for prostate cancer
Safety test of inserting small gold fiducials for prostate cancer
Safety test of inserting small gold fiducials for prostate cancer
Safety test of inserting small gold fiducials for prostate cancer
Japan |
Solid tumor
Radiology |
Malignancy
NO
To confirm the safety of radiotherapy for prostate cancer using Au fiducials with 1.5mm diameter
Safety
Confirmatory
Pragmatic
Phase I,II
Incidence of the Au marker invisibility for the usage of patient localization before and during radiotherapy
Incidence of the Au marker migration at one month after completion of the radiotherapy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Au marker in 1.5mm diameter
20 | years-old | <= |
Not applicable |
Male
1) Age 20-yrs old or over at the time of consent form is obtained.
2) PS is 0-3 in the criteria of ECOG.
3) Patients who are considered to be capable for insertion of Au marker (2.0mm in diameter) to the prostate gland for radiotherapy.
4) Explained well and consent to this study.
1) previous history of partial or total resection of prostate gland or bladder
2) the proposed radiation treatment site had been given tolerance dose in the past
3) cannot be held rest for about 30 minutes
4) weight over 135kg
5) with serious active infections in the irradiated sites
6) with severe diabetes that uncontrolled, or treated by using insulin
7) with pulmonary arteriovenous fistula, atrial heart septal defect, ventricular heart septal defect or other shunt between right and left heart
8) severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia
9) with the state of DIC, bleeding tendency, who cannot halt the anticoagulant therapy even the temporary.
10) considered that participation in this trial is difficult because of psychiatric symptoms or psychosis
11) allergic to au materials.
12) unsuitable for enrollment judged by principal investigator
100
1st name | Shinichi |
Middle name | |
Last name | Shimizu |
Hokkaido University Graduate School of Medicine
Department of Radiation Oncology
060-8638
North 15 West 7, Kita-Ku, Sapporo, Hokkaido
+81-11-706-5977
sshing@med.hokudai.ac.jp
1st name | Shinichi |
Middle name | |
Last name | Shimizu |
Hokkaido University Graduate School of Medicine
Department of Radiation Oncology
060-8638
North 15 West 7, Kita-Ku, Sapporo, Hokkaido
+81-11-706-5977
sshing@med.hokudai.ac.jp
Department of Radiation Oncology, Hokkaido University Graduate School of Medicine
None
Self funding
Hokkaido University Hospital Division of Clinical Research Administration
Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan
011-706-7636
crjimu@huhp.hokudai.ac.jp
NO
2014 | Year | 04 | Month | 15 | Day |
Unpublished
Terminated
2014 | Year | 04 | Month | 14 | Day |
2014 | Year | 04 | Month | 15 | Day |
2014 | Year | 04 | Month | 15 | Day |
2019 | Year | 03 | Month | 31 | Day |
2014 | Year | 04 | Month | 14 | Day |
2020 | Year | 04 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016012
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |